1-3 of 3
Rebecca Rich
Close
Sort by
Journal Articles

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Clinical Trials & Observations
Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Sundar Jagannath, Steven R. Zeldenrust, Melissa Alsina, Robert L. Schlossman, S. Vincent Rajkumar, K. Raman Desikan, Teru Hideshima, Nikhil C. Munshi, Kathleen Kelly-Colson, Deborah Doss, Mary L. McKenney, Svetlana Gorelik, Diane Warren, Andrea Freeman, Rebecca Rich, Anfang Wu, Marta Olesnyckyj, Kenton Wride, William S. Dalton, Jerome Zeldis, Robert Knight, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2006) 108 (10): 3458–3464.
https://doi.org/10.1182/blood-2006-04-015909
Published: 2006
Journal Articles

Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function

Brief Report
Abie Craiu, Yoriko Saito, Ana Limon, Henry M. Eppich, Douglas P. Olson, Neil Rodrigues, Gregor B. Adams, David Dombkowski, Paul Richardson, Robert Schlossman, Peter S. Choi, Jonathan Grogins, Paula G. O'Connor, Kenneth Cohen, Eyal C. Attar, Jay Freshman, Rebecca Rich, Joseph A. Mangano, John G. Gribben, Kenneth C. Anderson, David T. Scadden
Journal: Blood
Blood (2005) 105 (5): 2235–2238.
https://doi.org/10.1182/blood-2003-12-4399
Published: 2005
Journal Articles

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Clinical Trials & Observations
Paul G. Richardson, Robert L. Schlossman, Edie Weller, Teru Hideshima, Constantine Mitsiades, Faith Davies, Richard LeBlanc, Laurence P. Catley, Deborah Doss, Kathleen Kelly, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca Rich, Joan J. Ryoo, Dharminder Chauhan, Kathe Balinski, Jerome Zeldis, Kenneth C. Anderson
Journal: Blood
Blood (2002) 100 (9): 3063–3067.
https://doi.org/10.1182/blood-2002-03-0996
Published: 2002